Note: This is an archived Handbook entry from 2012.
|Dates & Locations:|| |
This subject has the following teaching availabilities in 2012:Semester 2, Parkville - Taught on campus.
Timetable can be viewed here. For information about these dates, click here.
|Time Commitment:||Contact Hours: 3 x one hour lectures per week (total contact hours: 36) |
Total Time Commitment:
Study Period Commencement:
Study Period Commencement:
Students wishing to undertake this subject as breadth will need the approval of the subject co-ordinator.
|Recommended Background Knowledge:|| |
|Non Allowed Subjects:|| |
This subject cannot be taken if credit has been previously obtained for 534-302 Neuropharmacology.
|Core Participation Requirements:||
It is University policy to take all reasonable steps to minimise the impact of disability upon academic study and reasonable steps will be made to enhance a student’s participation in the University’s programs.
CoordinatorAssoc Prof James Ziogas, Prof Peter Mcintyre
Dr Peter Crack
Prof Peter McIntyre
Ms Hong Nguyen
The workings of the brain present one of the last true unknowns in modern medicine and yet it is the target for a multitude of interesting and important drugs. This subject will address the use of drugs in modulating the processes of neurochemical transmission and neuronal survival in the context of the management of mood and emotional disorders, addictive behaviours, neuro-degenerative diseases, pain and epilepsy. This subject will also discuss strategies for the development of future therapeutics and students will gain an appreciation of how a detailed understanding of pathological processes is important for the rational development of new therapeutics.
On successful completion of this unit, students will have developed a solid understanding of the pharmacology of central nervous system diseases and the knowledge of the actions of important drugs used clinically and in research into central nervous system disorders
Students will also gain an appreciation of how a detailed understanding of pathological processes is important for the rational development of new therapeutics.
|Prescribed Texts:|| |
|Recommended Texts:|| |
Nestler, Hymen & Malenka,
|Breadth Options:|| |
This subject potentially can be taken as a breadth subject component for the following courses:
You should visit learn more about breadth subjects and read the breadth requirements for your degree, and should discuss your choice with your student adviser, before deciding on your subjects.
|Fees Information:||Subject EFTSL, Level, Discipline & Census Date|
By the end of this unit students will:
This subject is available to students enrolled in the BSc, Biomedicine degree.
Biomedical Biotechnology (specialisation of Biotechnology major) |
Science credit subjects* for pre-2008 BSc, BASc and combined degree science courses
Science-credited subjects - new generation B-SCI and B-ENG. Core selective subjects for B-BMED.
Download PDF version.